VeriMomIs palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine safe during pregnancy?
No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
Pregnancy-safe products containing palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine
Related ingredients
Frequently asked questions
- Is palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine safe during pregnancy?
- No harmonised CLP classification or SCCS/CIR reproductive safety restriction was found for this ingredient. No peer‑reviewed reproductive or developmental toxicity data were identified. As a large palmitoyl‑peptide used topically, dermal absorption is expected to be negligible, and there is no structural or mechanistic evidence of reproductive toxicity. Sources consulted include PubChem, CosIng, PubMed (no reproductive studies), ECHA (no Annex VI harmonised classification), and EWG.
- Is palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine safe while breastfeeding?
- No data indicating transfer into breast milk or lactation-related toxicity. Given the peptide's size/polarity and expected negligible systemic absorption after topical use, risk of exposure to breastfed infants is unlikely. No regulatory flags (ECHA Annex VI, SCCS, CIR) or peer‑reviewed evidence were found.
- Is palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine safe for baby skin?
- No infant‑specific reproductive or toxicology data located. Adult dermal absorption is expected negligible; however, infant skin has a higher surface‑area‑to‑weight ratio and immature barrier, so exposure score is increased by +1 for 0–3 yr. There is still no mechanistic or hazard evidence suggesting reproductive or developmental toxicity for infants.
- How does VeriMom score palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine?
- VeriMom scores palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine at 100/100 (no known risks) based on EU CosIng status, ECHA hazard classifications, and peer-reviewed PubMed studies. Our scoring pipeline is fully transparent.
- What are pregnancy-safe alternatives to palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine?
- See our curated list of pregnancy-safe alternatives to palmitoyl dipeptide-5 diaminobutyroyl hydroxythreonine based on similar function and a no-known-risks safety band.
Check every label in 2 seconds
Get VeriMom free — scan any product and see the pregnancy safety score instantly.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Safety scores are based on publicly available data and may not reflect all risks. Always consult your healthcare provider before using any product during pregnancy or breastfeeding.